Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer.
Davidson T, Amit U, Saad A, Hahiashvili M, Goshen E, Portnoy O, Berger R, Goldstein A, Sadetsky I, Weizman N, Chikman B, Dotan Z, Lawrence YR, Ben-Haim S, Symon Z, Goldstein J.
Davidson T, et al. Among authors: weizman n.
Nucl Med Commun. 2019 Sep;40(9):913-919. doi: 10.1097/MNM.0000000000001047.
Nucl Med Commun. 2019.
PMID: 31343612